Marshall Wace North America’s Covetrus, Inc. Common Stock CVET Stock Holding History

Marshall Wace North America’s Portfolio CVET Stock Details CVET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$4.28M	Buy	+235,963	New	+$5.41M	0.02%	555
2021 Q2	–	Sell	-9,070	Closed	-$272K	–	1923
2021 Q1	$272K	Buy	+9,070	New	+$309K	﹤0.01%	1339
2020 Q2	–	Sell	-9,076	Closed	-$74K	–	1581
2020 Q1	$74K	Buy	+9,076	New	+$104K	﹤0.01%	1037
2019 Q4	–	Sell	-11,621	Closed	-$138K	–	1704
2019 Q3	$138K	Buy	+11,621	New	+$215K	﹤0.01%	1012
2019 Q2	–	Sell	-38,251	Closed	-$1.22M	–	1763
2019 Q1	$1.22M	Buy	+38,251	New	+$1.36M	0.01%	636

Other funds holding CVET

CDR

Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

SCHF (GPE) Wilson, Wyoming $781M AUM 24.06% 1-Year Est. Return

FCM

Freshford Capital Management Rye Brook, New York $200M AUM 31.49% 1-Year Est. Return

Marshall Wace North America's CVET Position: Q3 2021 in Review

Marshall Wace North America opened a new position in Covetrus, Inc. Common Stock (CVET) in Q3 2021: 235,963 shares worth $4.28M. The stake represents 0.02% of the portfolio and ranks #555 among its holdings. This is a return to the name: Marshall Wace North America previously reported a position in CVET as recently as Q1 2021.

Marshall Wace North America first reported a position in CVET in Q1 2019 and has held it in 5 quarters since. 260 funds tracked by Wall St. Rank hold CVET as of Q3 2021.

Marshall Wace North America held 235,963 shares of Covetrus, Inc. Common Stock worth $4.28M as of Q3 2021.
Covetrus, Inc. Common Stock was a new Marshall Wace North America position in Q3 2021.
Covetrus, Inc. Common Stock made up 0.02% of Marshall Wace North America's portfolio in Q3 2021, its #555 holding.
Marshall Wace North America first reported a position in Covetrus, Inc. Common Stock in Q1 2019 and has held it in 5 quarters since.
260 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.